BioSig Announces Reverse Stock Split
31 janv. 2024 11h15 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company committed to delivering unprecedented accuracy and...
Revolutionising Facial Rejuvenation: McKeown Medical Release Comprehensive Guide to Cutting-Edge Facelift Techniques
31 janv. 2024 09h02 HE
|
McKeown Medical
Glasgow, Lanarkshire, Jan. 31, 2024 (GLOBE NEWSWIRE) -- McKeown Medical, a discrete centre of aesthetic excellence in Scotland that is led by award-winning doctor Dr Darren McKeown, who has become...
Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Spray
31 janv. 2024 08h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that it has filed a patent on its revyve™...
Medical pendant market Size Worth USD 719.8 Million in 2032 | Emergen Research
31 janv. 2024 08h15 HE
|
Emergen Research
Vancouver, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The global medical pendant market size was USD 399.1 Million in 2022 and is expected to register a rapid revenue CAGR of 6.1% during the forecast period....
SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY
30 janv. 2024 16h01 HE
|
SINTX Technologies, Inc.
SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT; “SINTX” or the “Company”), a manufacturer and developer of advanced ceramic materials and...
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
30 janv. 2024 08h30 HE
|
BioSig Technologies, Inc.
Cost Savings Targeted to Reduce Cash Burn by 50% Core Strategy Shifts to Business Development and Distribution Partnerships Westport, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) -- BioSig...
Hormone Replacement Therapy Market Surges, to Reach USD 50.5 Billion by 2033 with a 7.8% CAGR
29 janv. 2024 01h56 HE
|
MarketResearch.biz
New York, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The hormone replacement therapy was valued at USD 24.3 billion in 2023 with significant growth and is projected to reach at USD 50.5 billion by 2033 with...
Knock Out Opioid Abuse Day Learning Series Returns in 2024
24 janv. 2024 10h42 HE
|
Partnership for a Drug-Free New Jersey
Millburn, NJ, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Partnership for a Drug-Free New Jersey (PDFNJ), the Office of the New Jersey Coordinator for Addiction Responses and Enforcement Strategies (NJ...
ARA Develops Microrobot Control System for Targeted Drug Delivery Research
24 janv. 2024 09h30 HE
|
Applied Research Associates, Inc.
Albuquerque, New Mexico, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Albuquerque, N.M. - Applied Research Associates, Inc. (ARA) has developed a control system for precisely navigating microscopic robots...
Alkeus Pharmaceuticals Appoints Seemi Khan, M.D., Chief Medical Officer
23 janv. 2024 08h30 HE
|
Alkeus Pharmaceuticals
Alkeus Pharmaceuticals, Inc. announces that Seemi Khan, M.D., M.P.H., M.B.A., has joined the Company as Chief Medical Officer.